HSP90 Mediates IFNγ-Induced Adaptive Resistance to Anti-PD-1 Immunotherapy.
Ke LiuJun HuangJiao LiuChangfeng LiGuido KroemerDaolin TangRui KangPublished in: Cancer research (2022)
This study reveals an HSP90-centric, iron-modulated mechanism that confers immunosuppression, offering potential therapeutic targets for interfering with acquired resistance to the most prevalent anticancer immunotherapies.